RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q2 2025

Type / Class
Equity / Common Stock
Symbol
DNA on NYSE
Shares outstanding
382,523,969
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -30% $5,718,733 -$125,747 24,864,058 -1.5% BAILLIE GIFFORD & CO 31 Dec 2024

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (DNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$202,980 0
2025 Q1 606,634 $203,000 +$202,980 $0.33 1
2024 Q4 0 $0 -$128,803 0
2024 Q3 18,945 $125,460 -$301,865,384 $0.33 6
2024 Q2 932,591,724 $311,395,656 -$135,265,367 $0.33 305
2024 Q1 1,279,407,783 $1,484,427,678 +$9,015,916 $1.16 326
2023 Q4 12,831,259 $21,684,828 +$3,297,446 $1.69 4
2023 Q3 1,217,911,231 $2,204,549,681 +$42,629,461 $1.81 337
2023 Q2 1,142,524,104 $2,124,621,632 +$140,780,154 $1.86 300
2023 Q1 1,128,606,935 $1,500,151,552 +$186,785,213 $1.33 302
2022 Q4 989,676,080 $1,672,520,665 +$183,240,907 $1.69 306
2022 Q3 873,964,218 $2,728,613,428 +$301,604,098 $3.12 249
2022 Q2 697,065,726 $1,656,209,842 +$215,498,097 $2.38 239
2022 Q1 664,883,240 $2,671,303,810 -$1,021,852,905 $4.03 178
2021 Q4 896,687,035 $7,382,956,858 +$844,589,671 $8.31 153
2021 Q3 792,063,021 $9,177,441,180 +$9,177,093,199 $11.59 122
2020 Q2 15,000 $36,000 $0 $2.40 1